Connect with us

Technology

IAS Reports Fourth Quarter and Full Year 2023 Financial Results

Published

2 years ago

on

Fourth quarter revenue increased 14% to $134.3 million

Fourth quarter net income of $10.2 million at an 8% margin; fourth quarter adjusted EBITDA increased 19% to $47.5 million at a 35% margin

NEW YORK, Feb. 27, 2024 /PRNewswire/ — Integral Ad Science Holding Corp. (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced financial results for the fourth quarter and full year ended December 31, 2023.

“We ended 2023 with strong fourth quarter performance across optimization and measurement with revenue growth of 16% and 18%, respectively,” said Lisa Utzschneider, CEO of IAS. “Social media revenue increased 37% in the fourth quarter as marketers trusted IAS to maximize their advertising spend globally, particularly in short-form video. In 2024, we will continue to invest in data science and innovate with AI to empower marketers with actionable data to drive superior results. We expect to deliver double-digit revenue growth for the full year.”  

Fourth Quarter 2023 Financial Highlights

Total revenue was $134.3 million, a 14% increase compared to $117.4 million in the prior-year period.Optimization revenue was $63.6 million, a 16% increase compared to $55.1 million in the prior-year period.Measurement revenue was $52.6 million, an 18% increase compared to $44.7 million in the prior-year period.Publisher revenue was $18.1 million, a 2% increase compared to $17.6 million in the prior-year period.International revenue, excluding the Americas, was $43.3 million, a 16% increase compared to $37.3 million in the prior-year period, or 32% of total revenue for the fourth quarter of 2023.Gross profit was $106.0 million, an 11% increase compared to $95.5 million in the prior-year period. Gross profit margin was 79% for the fourth quarter of 2023.Net income was $10.2 million, or $0.06 per basic and diluted share, compared to $11.5 million, or $0.07 per basic and diluted share, in the prior-year-period. Net income margin was 8% for the fourth quarter of 2023.Adjusted EBITDA* was $47.5 million, a 19% increase compared to $40.0 million in the prior-year period. Adjusted EBITDA* margin was 35% for the fourth quarter of 2023.

Full Year 2023 Financial Highlights

Total revenue was $474.4 million, a 16% increase compared to $408.3 million in the prior year.Optimization revenue was $224.5 million, an 18% increase compared to $190.6 million in the prior year.Measurement revenue was $186.0 million, a 20% increase compared to $154.9 million in the prior year.Publisher revenue was $63.8 million, a 2% increase compared to $62.8 million in the prior year.International revenue, excluding the Americas, was $146.8 million, a 14% increase compared to $129.1 million in the prior year, or 31% of total revenue for the full year 2023.Gross profit was $375.0 million, a 13% increase compared to $332.6 million in the prior year. Gross profit margin was 79% for the full year 2023.Net income was $7.2 million, or $0.04 per diluted share, compared to $15.4 million, or $0.10 per basic and diluted share, in the prior year. Net income margin was 2% for the full year 2023.Adjusted EBITDA* was $159.5 million, a 26% increase compared to $126.6 million in the prior year. Adjusted EBITDA* margin was 34% for the full year 2023.Cash and cash equivalents were $124.8 million at December 31, 2023.

Recent Business Highlights

Meta Expansion – In February, IAS announced the availability of its AI-driven Total Media Quality (TMQ) brand safety and suitability measurement product across Facebook and Instagram Feed and Reels. IAS’s new post-bid brand safety and suitability expansion with Meta gives advertisers increased transparency into whether their campaigns are appearing next to safe and suitable content.IAS MRC Continuing Accreditation for Measurement of Meta Platforms – In January, IAS received continuing accreditation from the MRC for viewability measurement of Meta, including impressions and two-second video viewability, on Facebook Feed and Instagram Feed and Stories.YouTube TMQ Expansion – During the fourth quarter, IAS expanded its partnership to YouTube Shorts to offer its brand safety and suitability measurement product to advertisers for YouTube Shorts inventory, as part of its existing Total Media Quality for YouTube product suite.X Expansion – In February, IAS expanded its partnership with X to all U.S. advertisers. IAS classifies all vertical video ad adjacencies for brand safety and suitability aligned to the GARM framework, giving advertisers maximum control over where their ads appear on the X vertical video feed.Quality Attention Expansion – In January, IAS announced the general availability of its Quality Attention measurement product. Quality Attention uses advanced machine learning technology, actionable data from Lumen Research’s eye-tracking technology, and a variety of signals obtained as part of IAS’s core technology.

Financial Outlook

“We reported profitable growth in the fourth quarter with a 14% revenue increase at a 35% adjusted EBITDA* margin,” said Tania Secor, CFO of IAS. “As we move through 2024, we expect to ramp both revenue growth and profitability from forecasted first quarter levels as we expand availability and customer adoption of new products. We also plan to maintain our strong financial profile and healthy balance sheet.”

IAS is introducing the following financial outlook for the first quarter and full year 2024:

First Quarter Ending March 31, 2024:

Total revenue of $111 million to $113 millionAdjusted EBITDA* of $28 million to $30 million

Year Ending December 31, 2024:

Total revenue of $530 million to $540 millionAdjusted EBITDA* of $171 million to $179 million

* See “Supplemental Disclosure Regarding Non-GAAP Financial Information” section herein for an explanation of Non-GAAP measures. IAS is unable to provide a reconciliation for forward-looking guidance of Adjusted EBITDA to net income (loss), the most closely comparable GAAP measure, because certain material reconciling items, such as depreciation and amortization, interest expense, income tax expense (benefit), restructuring and severance costs, and acquisition and integration costs, cannot be estimated due to factors outside of IAS’s control and could have a material impact on the reported results. However, IAS estimates stock-based compensation expense for the first quarter of 2024 in the range of $14 million to $16 million and for the full year 2024 in the range of $72 million to $76 million. A reconciliation is not available without unreasonable effort.

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONSOLIDATED BALANCE SHEETS

 

(IN THOUSANDS, EXCEPT SHARE DATA)

December 31, 2023

December 31, 2022

ASSETS

Current assets:

Cash and cash equivalents

$      124,759

$        86,877

Restricted cash

54

45

Accounts receivable, net

74,609

67,884

Unbilled receivables

46,548

41,550

Prepaid expenses and other current assets

18,959

24,761

Due from related party

—

29

Total current assets

264,929

221,146

Property and equipment, net

3,769

2,412

Internal use software, net

40,301

23,642

Intangible assets, net

178,908

217,558

Goodwill

675,282

674,094

Operating lease right-of-use assets, net

21,668

22,787

Deferred tax asset, net

2,465

2,020

Other long-term assets

4,402

5,024

Total assets

$   1,191,724

$   1,168,683

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable and accrued expenses

$        72,232

$        60,799

Operating lease liabilities, current

9,435

6,749

Due to related party

121

122

Deferred revenue

682

99

Total current liabilities

82,470

67,769

Deferred tax liability, net

20,367

45,495

Long-term debt

153,725

223,262

Operating lease liabilities, non-current

19,523

22,875

Other long-term liabilities

6,183

1,066

Total liabilities

282,268

360,467

Commitments and Contingencies

Stockholders’ Equity

Preferred Stock, $0.001 par value, 50,000,000 shares authorized at December 31, 2023; 0
     shares issued and outstanding at December 31, 2023 and 2022

—

—

Common Stock, $0.001 par value, 500,000,000 shares authorized at December 31, 2023,
     158,757,620 and 153,990,128 shares issued and outstanding at December 31, 2023 and
     2022, respectively

159

154

Additional paid-in-capital

901,259

810,186

Accumulated other comprehensive loss

(916)

(2,899)

Accumulated earnings

8,954

775

Total stockholders’ equity

909,456

808,216

Total liabilities and stockholders’ equity

$   1,191,724

$   1,168,683

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(UNAUDITED)

Three months ended December 31,

Year ended December 31,

(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

2023

2022

2023

2022

Revenue

$       134,295

$       117,435

$      474,369

$      408,348

Operating expenses:

Cost of revenue (excluding depreciation and amortization shown below)

28,252

21,891

99,352

75,755

Sales and marketing

30,423

28,325

117,989

106,286

Technology and development

19,056

22,280

72,906

76,351

General and administrative

25,961

23,572

111,634

79,654

Depreciation and amortization

14,593

12,811

54,966

50,396

Foreign exchange (gain) loss, net

(501)

1,246

430

4,749

Total operating expenses

117,784

110,125

457,277

393,191

Operating income

16,511

7,310

17,092

15,157

Interest expense, net

(2,489)

(3,194)

(12,236)

(9,053)

Employee retention tax credit

—

—

—

6,981

Net income before income taxes

14,022

4,116

4,856

13,085

(Provision) benefit from income taxes

(3,858)

7,371

2,382

2,288

Net income

$         10,164

$         11,487

$          7,238

$        15,373

Net income per share:

Basic

$             0.06

$             0.07

$           0.05

$           0.10

Diluted

$             0.06

$             0.07

$           0.04

$           0.10

Weighted average shares outstanding:

Basic

158,243,619

153,792,438

156,272,335

154,699,694

Diluted

163,060,805

155,288,725

161,723,131

157,258,083

Other comprehensive income:

Foreign currency translation adjustments

2,772

8,634

1,983

(2,584)

Total comprehensive income

$         12,936

$         20,121

$          9,221

$        12,789

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’/MEMBERS’ EQUITY

Members’ Interest

Common Stock

(IN THOUSANDS, EXCEPT UNITS
AND SHARES DATA)

Units

Amount

Shares

Amount

Additional

paid-in

capital

Accumulated

other

comprehensive

income (loss)

Accumulated
earnings

(deficit)

Total members’/
stockholders’ 
equity

Balances at January 1, 2021

134,039,494

$            553,717

—

$                     —

$                     —

$               4,523

$          (126,761)

$            431,479

Repurchase of units

(99,946)

(413)

—

—

—

—

(791)

(1,204)

Units vested

17,486

—

—

—

—

—

—

—

Option exercises

246,369

1,075

—

—

3,360

—

—

4,435

Foreign currency translation
adjustment

—

—

—

—

—

(4,838)

—

(4,838)

Net loss prior to corporate conversion

—

—

—

—

—

—

(37,832)

(37,832)

Conversion to Delaware corporation

(134,203,403)

(554,379)

134,203,403

134

388,860

—

165,385

—

Rounding units/shares as a result of
corporate conversion

—

—

(17)

—

—

—

—

—

Stock-based compensation

—

—

—

—

55,222

—

—

55,222

RSUs vested

—

—

26,931

—

150

—

—

150

Issuance of common stock in
connection with initial public offering

—

—

16,821,330

17

274,340

—

—

274,357

Issuance of common stock for Publica
acquisition

—

—

2,888,889

3

49,628

—

—

49,631

Issuance of common stock for Context
acquisition

—

—

457,959

—

10,391

—

—

10,391

Net loss

—

—

—

—

—

—

(14,600)

(14,600)

Balances at December 31, 2021

—

$                     —

154,398,495

$                  154

$            781,951

$                 (315)

$            (14,600)

$            767,190

RSUs vested

—

—

1,084,966

1

—

—

—

1

Option exercises

—

—

1,586,728

2

7,153

—

—

7,155

Stock-based compensation

—

—

—

—

44,733

—

—

44,733

Foreign currency translation
adjustment

—

—

—

—

—

(2,584)

—

(2,584)

Repurchase of common stock

—

—

(3,080,061)

(3)

(23,652)

—

—

(23,655)

Net income

—

—

—

—

—

—

15,373

15,373

Balances at December 31, 2022

—

$                     —

153,990,128

$                  154

$            810,186

$              (2,899)

$                  775

$            808,216

RSUs and MSUs vested

—

—

3,492,130

4

—

—

—

4

Option exercises

—

—

1,001,793

1

7,988

—

—

7,989

ESPP purchase

—

—

273,569

—

2,306

—

—

2,306

Stock-based compensation

—

—

—

—

80,779

—

—

80,779

Foreign currency translation adjustment

—

—

—

—

—

1,983

—

1,983

Adoption of ASC 326, net of tax

—

—

—

—

—

—

941

941

Net income

—

—

—

—

—

—

7,238

7,238

Balances at December 31, 2023

—

$                     —

158,757,620

$                  159

$            901,259

$                 (916)

$               8,954

$            909,456

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

Year ended December 31,

(IN THOUSANDS)

2023

2022

Cash flows from operating activities:

Net income

$          7,238

$        15,373

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

54,966

50,396

Stock-based compensation

81,103

44,752

Foreign exchange (gain) loss, net

(484)

5,233

Deferred tax benefit

(21,531)

(8,880)

Amortization of debt issuance costs

463

464

Allowance for credit losses

3,816

1,837

Employee retention tax credit

—

(6,981)

Impairment of assets

33

974

Changes in operating assets and liabilities:

Increase in accounts receivable

(8,148)

(18,581)

Increase in unbilled receivables

(4,685)

(5,830)

Decrease (increase) in prepaid expenses and other current assets

6,418

(10,641)

Increase in operating leases, net

(29)

(852)

Decrease (increase) in other long-term assets

375

(1,057)

Increase in accounts payable and accrued expenses and other long-term liabilities

11,478

6,286

Increase (decrease) in deferred revenue

582

(88)

Increase in due to/from related party

28

62

Net cash provided by operating activities

131,623

72,467

Cash flows from investing activities:

Payment for acquisitions, net of acquired cash

(966)

(1,603)

Purchase of property and equipment

(1,975)

(2,016)

Acquisition and development of internal use software and other

(31,777)

(14,673)

Net cash used in investing activities

(34,718)

(18,292)

Cash flows from financing activities:

Repayment of long-term debt

(145,000)

(35,000)

Repayment of short-term debt

—

(1,816)

Proceeds from the Revolver

75,000

15,000

Proceeds from exercise of stock options

7,989

7,155

Payments for repurchase of common stock

—

(23,655)

Cash received from Employee Stock Purchase Program (ESPP)

3,160

845

Net cash used in financing activities

(58,851)

(37,471)

Net increase in cash, cash equivalents, and restricted cash

38,054

16,704

Effect of exchange rate changes on cash and cash equivalents, and restricted cash

(435)

(3,111)

Cash, cash equivalents, and restricted cash, at beginning of year

89,671

76,078

Cash, cash equivalents, and restricted cash, at end of year

$      127,290

$        89,671

Supplemental Disclosures:

Cash paid during the year for:

Interest

$        11,229

$          8,511

Taxes

$        10,985

$        16,396

Non-cash investing and financing activities:

Property and equipment acquired included in accounts payable

$             431

$               97

Internal use software acquired included in accounts payable

$          1,444

$          1,517

Lease liabilities arising from right of use assets

$          6,282

$        29,624

Supplemental Disclosure Regarding Non-GAAP Financial Information

We use supplemental measures of our performance, which are derived from our consolidated financial information, but which are not presented in our consolidated financial statements prepared in accordance with GAAP. Adjusted EBITDA is the primary financial performance measure used by management to evaluate our business and monitor ongoing results of operations. Adjusted EBITDA is defined as income/loss before depreciation and amortization, stock-based compensation, interest expense, income taxes, restructuring and severance costs, acquisition and integration costs, foreign exchange gains and losses, and other one-time, non-recurring costs. Adjusted EBITDA margin represents the adjusted EBITDA for the applicable period divided by the revenue for that period presented in accordance with GAAP.

We use non-GAAP financial measures to supplement financial information presented on a GAAP basis. We believe that excluding certain items from our GAAP results allows management to better understand our consolidated financial performance from period to period and better project our future consolidated financial performance as forecasts are developed at a level of detail different from that used to prepare GAAP-based financial measures. Moreover, we believe these non-GAAP financial measures provide our shareholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and enabling them to make more meaningful period-to-period comparisons. Although we believe these measures are useful to investors and analysts for the same reasons they are useful to management, these measures are not a substitute for, or superior to, U.S. GAAP financial measures or disclosures. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Reconciliation of historical Adjusted EBITDA and corresponding margin to their most directly comparable GAAP financial measures, net income/loss and corresponding margin are presented below. We encourage you to review the reconciliations in conjunction with the presentation of the non-GAAP financial measures for each of the periods presented. In future fiscal periods, we may exclude such items and may incur income and expenses similar to these excluded items.

Reconciliation of Adjusted EBITDA

Three months ended December 31,

Year ended December 31,

(in thousands, except percentages)

2023

2022

2023

2022

Net income

$       10,164

$       11,487

$         7,238

$      15,373

Depreciation and amortization

14,593

12,811

54,966

50,396

Stock-based compensation

15,462

11,645

81,103

44,752

Interest expense, net

2,489

3,194

12,236

9,053

Provision (benefit) from income taxes

3,858

(7,371)

(2,382)

(2,288)

Restructuring and severance costs

1,054

5,904

4,028

10,321

Acquisition and integration costs

—

118

—

97

Foreign exchange (gain) loss, net

(501)

1,246

430

4,798

Employee retention tax credit

—

—

—

(6,981)

Offering costs, impairments and other costs

396

1,003

1,913

1,058

Adjusted EBITDA

$       47,515

$       40,037

$     159,532

$    126,579

Revenue

$     134,295

$     117,435

$     474,369

$    408,348

Net income margin

8 %

10 %

2 %

4 %

Adjusted EBITDA margin

35 %

34 %

34 %

31 %

 

Stock-Based Compensation 

Three months ended December 31,

Year ended December 31,

(in thousands)

2023

2022

2023

2022

Cost of revenue

$             124

$             249

$             452

$             507

Sales and marketing

5,512

2,871

23,371

13,520

Technology and development

4,104

2,958

17,538

9,937

General and administrative

5,722

5,567

39,742

20,788

Total stock-based compensation

$         15,462

$         11,645

$         81,103

$         44,752

Conference Call and Webcast Information
IAS will host a conference call and live webcast to discuss its fourth quarter and full year 2023 financial results today at 5:00 p.m. ET. To access the live webcast and conference call dial-in, please register under the “News & Events” section of IAS’s investor relations website. A replay will be available on IAS’s investor relations website following the live call: https://investors.integralads.com.

About Integral Ad Science
Integral Ad Science (IAS) is a leading global media measurement and optimization platform that delivers the industry’s most actionable data to drive superior results for the world’s largest advertisers, publishers, and media platforms. IAS’s software provides comprehensive and enriched data that ensures ads are seen by real people in safe and suitable environments, while improving return on ad spend for advertisers and yield for publishers. Our mission is to be the global benchmark for trust, safety, and transparency in digital media quality. For more information, visit integralads.com.

Forward-Looking Statements
This earnings press release contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely,” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected costs, expenditures, cash flows, growth rates and financial results or our plans and objectives for future operations, growth initiatives or strategies are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including: (i) the adverse effect on our business, operating results, financial condition, and prospects from various macroeconomic factors, including instability in geopolitical or market conditions; (ii) our failure to innovate or make the right investment decisions; (iii) our ability to provide digital or cross-platform analytics; (iv) our failure to maintain or achieve industry accreditation standards; (v) our dependence on integrations with advertising platforms, demand side providers (“DSPs”) and proprietary platforms that we do not control; (vi) our ability to compete successfully with our current or future competitors in an intensely competitive market; (vii) our inability to use software licensed from third parties; (viii) our international expansion; (ix) our ability to expand into new channels; (x) our ability to sustain our profitability and revenue growth rate; (xi) risks that our customers do not pay or choose to dispute their invoices; (xii) risks of material changes to revenue share agreements with certain DSPs; (xiii) our dependence on the overall demand for advertising; (xiv) our ability to effectively manage our growth; (xv) the impact that any acquisitions we have completed in the past and may consummate in the future, strategic investments, or alliances may have on our business, financial condition, and results of operations; (xvi) our ability to successfully execute our international plans; (xvii) the risks associated with the seasonality of our market; (xviii) our ability to maintain high impression volumes; (xix) the difficulty in evaluating our future prospects given our short operating history; (xx) uncertainty in how the market for buying digital advertising verification solutions will evolve; (xxi) interruption by man-made problems such as terrorism, computer viruses, or social disruptions; (xxii) the risk of failures in the systems and infrastructure supporting our solutions and operations; (xxiii) our ability to avoid operational, technical, and performance issues with our platform; (xxiv) risks associated with any unauthorized access to user, customer, or inventory and third-party provider data; (xxv) our ability to provide the non-proprietary technology, software, products, and services that we use; (xxvi) the risk that we are sued by third parties for alleged infringement, misappropriation, or other violation of their proprietary rights; (xxvii) our ability to obtain, maintain, protect, or enforce intellectual property and proprietary rights that are important to our business; (xxviii) our involvement in lawsuits to protect or enforce our intellectual property; (xxix) risks that our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers; (xxx) risks that our trademarks and trade names are not adequately protected; (xxxi) the impact of unforeseen changes to privacy and data protection laws and regulation on digital advertising; (xxxii) our ability to maintain our corporate culture; (xxxiii) public health outbreaks, epidemics, pandemics, or other public health crises; (xxxiv) risks posed by earthquakes, fires, floods, and other natural catastrophic events; (xxxv) the risk that a perceived failure to comply with laws and industry self-regulation may damage our reputation; and (xxxvi) other factors disclosed in our filings with the SEC. Given these factors, as well as other variables that may affect our operating results, you should not rely on forward-looking statements, assume that past financial performance will be a reliable indicator of future performance, or use historical trends to anticipate results or trends in future periods.

We derive many of our forward-looking statements from our operating budgets and forecasts, which are based on many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to update or revise any forward- looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Investor Contact:
Jonathan Schaffer / Lauren Hartman
ir@integralads.com

Media Contact:
press@integralads.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ias-reports-fourth-quarter-and-full-year-2023-financial-results-302073075.html

SOURCE Integral Ad Science, Inc.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Composers for Wicked: For Good, Palm Royale, Pluribus, Stranger Things, The Age of Disclosure, Hurricane Katrina: Race Against Time, and Video Game Star Wars Outlaws: A Pirate’s Fortune Receive 2026 ASCAP Composers’ Choice Awards

Published

28 minutes ago

on

April 29, 2026

By

ASCAP Honors David Vanacore with Golden Note Award

LOS ANGELES, April 29, 2026 /PRNewswire/ — This evening, at its exclusive ASCAP Screen Celebrates event in Los Angeles, ASCAP (The American Society of Composers, Authors and Publishers) announced the 2026 ASCAP Composers’ Choice Awards honorees along with the ASCAP Screen Music Awards winners behind today’s most compelling film, television and video game music.

The ASCAP Screen Music Awards celebrate composers whose work elevates the art of visual storytelling across film, television and interactive media. Included in these are the ASCAP Composers’ Choice Awards, which are chosen by the ASCAP composer and songwriter community, an exclusive honor among US performing rights organizations. The 2026 winners, selected from a competitive field of nominees, created music for a critically acclaimed television comedy-drama series, a major cinematic musical adaptation, a landmark historical documentary series, and a standout fantasy-adventure video game, among others:

2026 ASCAP Composers’ Choice Award Winners

Film Score of the Year: Wicked: For Good – John Powell & Stephen SchwartzTelevision Score of the Year: Palm Royale – Jeff ToyneTelevision Theme of the Year: Pluribus – Dave Porter; Stranger Things – Kyle Dixon & Michael Stein (tie)Documentary Film Score of the Year: The Age of Disclosure – Blair Mowat Documentary Series Score of the Year: Hurricane Katrina: Race Against Time – Amanda Jones Video Game Score of the Year: Star Wars Outlaws: A Pirate’s Fortune – Wilbert Roget II, Jon Everist and Cody Matthew Johnson

In other categories, while Michael Giacchino received Top Domestic Box Office Film of the Year for Zootopia 2. Jake Staley earned Top Network Television Series for his work on the drama High Potential, and John Sereda received Top Cable Television Series for the historical drama When Calls the Heart. David Vanacore was the top winner in the Most Performed Themes & Underscore category.

This marked Vanacore’s 22nd consecutive win in the Most Performed Themes and Underscore category, and his 11th consecutive time as the top winner. During the celebration, Vanacore was also presented with ASCAP’s prestigious Golden Note Award in recognition of his extraordinary career achievements and impact on television music. A pioneering force in unscripted scoring, Vanacore has composed the music for CBS’s Survivor since its debut in 2000, with 2026 marking the series’ landmark 50th season.

ASCAP’s Golden Note Award is presented to artists who have achieved extraordinary career milestones. Previous recipients include Lionel Richie, Jeff Lynne, Quincy Jones, Jermaine Dupri, Reba McEntire, Alicia Keys and composers Alf Clausen and Mark Snow.

The complete list of winners is available on the ASCAP website: www.ascap.com/screenawards26

About ASCAP
The American Society of Composers, Authors and Publishers (ASCAP) is a membership association of more than 1.1 million songwriters, composers and music publishers, and represents some of the world’s most talented music creators. Founded and governed by songwriters, composers and publishers, it returns nearly 90 cents of every dollar collected to its members as royalties and has the lowest overhead rate of any U.S. PRO. ASCAP licenses a repertory of over 20 million musical works to hundreds of thousands of businesses that use music, including streaming services, cable television, radio and satellite radio and brick and mortar businesses such as retail stores, hotels, clubs, restaurants and bars. ASCAP collects the licensing fees and identifies, matches, processes and pays royalties to its members for trillions of performances every year. The ASCAP blanket license offers an efficient solution for businesses to legally perform ASCAP music while respecting the right of songwriters and composers to be paid fairly. ASCAP puts music creators first, advocating for their rights and the value of music on Capitol Hill, driving innovation that moves the industry forward, building community and providing the resources and support that creators need to succeed in their careers. Learn more and stay in touch at www.ascap.com, on X and Instagram @ASCAP and on Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/composers-for-wicked-for-good-palm-royale-pluribus-stranger-things-the-age-of-disclosure-hurricane-katrina-race-against-time-and-video-game-star-wars-outlaws-a-pirates-fortune-receive-2026-ascap-composers-choice-awards-302756632.html

SOURCE ASCAP – American Society of Composers, Authors and Publishers

Continue Reading

Technology

28.13%, 26.4%! LONGi Sets New World Records for Crystalline Silicon Solar Cell and Module Efficiency

Published

28 minutes ago

on

April 29, 2026

By

XI’AN, China, April 29, 2026 /PRNewswire/ — Recently, LONGi announced two major technological breakthroughs. First, its independently developed Hybrid Interdigitated-Back-Contact (HIBC) solar cell has been certified by the Institute for Solar Energy Research Hamelin (ISFH) in Germany, achieving a photoelectric conversion efficiency of 28.13%. This marks yet another step forward toward the theoretical efficiency limit of crystalline silicon solar cells, following LONGi’s previous efficiency record of 28.04% set in January 2026. Second, modules fabricated based on HIBC solar cells have been certified by the U.S. National Laboratory of the Rockies(NLR), with efficiency breaking through to 26.4% — setting a new record after LONGi had earlier pushed the crystalline silicon module efficiency to 26%.

As the ultimate solution for single-junction crystalline silicon cell technology, the HIBC cell developed by LONGi’s Central R&D Institute represents a culmination of the strengths of various cell technologies. The R&D team has innovatively introduced core technologies such as in-situ Patterned Edge Passivation (iPET) and Laser-Induced Crystallization modification (LIC). Through systematic optimization of structural design, material selection, and fabrication processes, the team has achieved multiple breakthroughs in optical performance, interface passivation quality, and charge transport efficiency, paving a mature pathway for the commercial deployment of ultra-high-efficiency crystalline silicon cells.

These hardcore breakthroughs in technological strength have already translated into a leading edge in mass production. In April 2026, the authoritative global PV media outlet TaiyangNews released its ranking of commercialized mass-produced module efficiencies, and LONGi’s  EcoLife series modules, powered by HIBC technology, secured the top spot with a mass-production efficiency of 25%. This achievement marks the official completion of a complete closed loop spanning from laboratory R&D to large-scale commercial application for HIBC cells, delivering yet another premium clean energy solution to global customers — one that offers “high efficiency, high energy yield, aesthetic versatility, and certified safety and reliability”.

Having been deeply engaged in the clean energy field for many years, LONGi has established a comprehensive “Green Power + Green Hydrogen + Energy Storage” full-chain clean energy solution, consistently driving technological iteration through independent innovation to deliver high-quality products across all application scenarios to global customers. Moving forward, LONGi will continue to focus on technological innovation, accelerating the translation of laboratory efficiency breakthroughs into large-scale manufacturing, and serving the global energy transition with more competitive clean energy products to help build a zero-carbon and sustainable green energy ecosystem.

SOURCE LONGi

Continue Reading

Technology

DentScribe Is Not Just an AI Scribe; It Supports the Entire Dental Day

Published

28 minutes ago

on

April 29, 2026

By

From the morning huddle to chairside review, notes, perio charting, treatment coordination, after-care, and follow-up, DentScribe helps busy dentists and DSOs see the full power of dental AI.

SUNNYVALE, Calif., April 29, 2026 /PRNewswire/ — A dentist’s day is not one task. It is a chain reaction.

DentScribe transforms the dental day – from morning huddle to follow-up – into connected, actionable intelligence.

It starts before the first patient sits down. The team has only a few minutes for the morning huddle. Who is coming in today? What did we miss last time? Which patients have unscheduled treatment? Which issues need attention before they become bigger problems?

Then the dentist walks into the operatory and needs instant context. What is in the chart? What did the patient defer? What did the provider recommend at the last visit? What should not be missed today?

Then comes the appointment itself: diagnosis, treatment, patient education, clinical judgment, documentation, perio charting, billing support, and follow-up planning.

And when the patient leaves the chair, the work is still not done. The treatment coordinator must explain the plan, discuss cost, review financing or insurance, handle hesitation, schedule the next visit, and make sure the patient understands what happens next.

This is why DentScribe is built to be more than an AI scribe.

DentScribe today reinforced the full range of its AI platform for dental practices and DSOs – a connected suite of capabilities designed to support the busy dentist and team across the dental day, from preparation to patient care to follow-up.

“Dentists do not experience their day as isolated tasks,” said Dr. Vinni K. Singh, Founder & CEO of DentScribe. “The morning huddle affects the chairside conversation. The chairside conversation affects the SOAP note. The SOAP note is the ground truth for production opportunities, treatment coordination, after-care, and doctor communications. DentScribe brings those pieces together so AI can support the real workflow of the dental office.”

The DentScribe ‘aha’ is simple: the note is only the beginning.

A SOAP note contains the dentist’s true clinical assessment. DentScribe turns that ground truth into action across the practice.

Before the day begins, DentScribe GPS helps the team prepare with a smarter morning huddle.Before and during the appointment, DentScribe CoPilot helps surface chairside reminders and unresolved opportunities.During and after care, DentScribe helps generate comprehensive SOAP notes and supports AI voice perio charting.After the appointment, DentScribe Treatment Coordinator Notes help document the financial and scheduling conversation.Before the patient forgets, DentScribe After-Care Summaries help explain what happened, what matters, and what comes next.When another provider needs context, DentScribe supports referral letters, specialist reports, and doctor communications.Across the office, DentScribe supports PMS-connected workflows, CDT-aware documentation, and practice-specific templates.

For busy dentists, that means less time buried in notes and fewer missed details.

For front-desk and treatment teams, it means clearer handoffs, better follow-up, and a more consistent way to document patient concerns.

For patients, it means a smoother experience, clearer next steps, and a better understanding of the care being recommended.

For DSOs and practice owners, it means DentScribe is not merely a documentation tool. It is an AI operating layer that can help reveal missed opportunities, reduce leakage, improve communication, and give leaders better visibility into the daily workflow of the practice.

“DentScribe’s ground-truth approach is powerful because it starts with what the dentist actually said, observed, and recommended,” said Dr. Ratinder Paul Singh Ahuja, Board Chair of DentScribe. “When that information becomes structured and actionable across the practice, AI becomes far more than a scribe – it becomes a system for better care delivery and production.”

DentScribe’s platform was designed for the reality of modern dentistry: fragmented systems, tight schedules, incomplete handoffs, late-night charting, missed follow-ups, and lost production. By bringing together documentation, CoPilot intelligence, GPS morning huddle insights, perio charting, treatment coordination, after-care, doctor communications, and PMS integration, DentScribe gives dental teams a clearer way to manage the full patient workflow.

The result is the “aha” moment many dentists and DSOs are looking for: An AI agent that optimizes their entire patient care workflow.

Ready to see the full DentScribe platform? Book a live demo: https://www.dentscribe.ai/book-a-demo

About DentScribe
DentScribe  is the agentic AI platform for dental documentation and production. DentScribe automatically generates comprehensive SOAP notes from dentist-patient conversations and publishes them directly into leading practice management systems. With DentScribe CoPilot, those notes become chairside checklists that close care gaps and increase case acceptance. With DentScribe GPS, leaders gain a practice-wide daily brief that turns morning huddles into a reliable engine for production and patient outcomes. Founded by practicing dentist Dr. Vinni K. Singh in Sunnyvale, California, DentScribe helps dentists reclaim time, deliver better care, and grow their practices – without changing how they work. Learn more or book a demo at dentscribe.ai.

Media Contact
DentScribe Media Relations
hello@dentscribe.ai
+1-650-446-6161
710 Lakeway Dr. #200, Sunnyvale, CA 94085

View original content to download multimedia:https://www.prnewswire.com/news-releases/dentscribe-is-not-just-an-ai-scribe-it-supports-the-entire-dental-day-302756661.html

SOURCE DentScribe

Continue Reading

Trending